Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CombiMatrix Corp (CBMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/15/2017 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Agreement and Plan of Merger and Reorganization, by and among the Company, Invitae and Merger Sub (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on July 31, 2017)",
"Amended and Restated Certificate of Incorporation of the Company",
"Amended and Restated Bylaws of the Company"
11/13/2017 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "COMBIMATRIX CORPORATION STOCKHOLDERS APPROVE MERGER AGREEMENT WITH INVITAE CORPORATION"
11/06/2017 8-K Quarterly results
Docs: "COMBIMATRIX CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Revenues: Diagnostic services $ 3,977 $ 3,211 $ 11,949 $ 9,190 Royalties 35 37 91 137 Total revenues 4,012 3,248 12,040 9,327 Operating expenses: Cost of services 1,614 1,476 4,754 4,327 Research and development 90 88 260 380 Sales and marketing 967 1,055 3,005 3,532 General and administrative 1,930 1,450 5,449 4,562 Patent amortization and royalties 25 25 75 75 Total operating expenses 4,626 4,094 13,543 12,876 Operating loss Other income : Interest income 7 7 18 19 Interest expense Total other income 4 5 Net loss $ $ $ $ Deemed dividend from issuing Series F convertible preferred stock and warrants $ - $ - $ - $ Deemed dividend paid for r..."
11/01/2017 8-K Other Events, Financial Statements and Exhibits
Docs: "Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote “FOR” the Proposed Merger with Invitae Corporation"
09/26/2017 8-K Quarterly results
09/25/2017 8-K Quarterly results
08/03/2017 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "COMBIMATRIX CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended Six Months Ended June 30, June 30, 2017 2016 2017 2016 Revenues: Diagnostic services $ 4,214 $ 3,049 $ 7,972 $ 5,979 Royalties 27 58 56 100 Total revenues 4,241 3,107 8,028 6,079 Operating expenses: Cost of services 1,632 1,432 3,140 2,851 Research and development 85 149 170 292 Sales and marketing 1,016 1,141 2,038 2,477 General and administrative 1,855 1,586 3,519 3,112 Patent amortization and royalties 25 25 50 50 Total operating expenses 4,613 4,333 8,917 8,782 Operating loss Other income : Interest income 5 8 11 12 Interest expense Total other income 2 1 Net loss $ $ $ $ Deemed dividend from issuing Series F convertible preferred stock and warrants $ - $ - $ - $ Deemed dividend paid for right to repu..."
07/31/2017 8-K Form 8-K - Current report:
06/19/2017 8-K Form 8-K - Current report
05/04/2017 8-K Form 8-K - Current report
03/01/2017 8-K Form 8-K - Current report
02/22/2017 8-K Form 8-K - Current report
02/03/2017 8-K Form 8-K - Current report
12/23/2016 8-K Form 8-K - Current report
11/02/2016 8-K Form 8-K - Current report
08/03/2016 8-K Form 8-K - Current report
07/11/2016 8-K Form 8-K - Current report
06/21/2016 8-K Form 8-K - Current report
05/04/2016 8-K Form 8-K - Current report
04/27/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2016 Executive Performance Bonus Plan"
03/24/2016 8-K Form 8-K - Current report
02/17/2016 8-K Quarterly results
Docs: "CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-implantation Genetic Screening Test Volumes Conference Call Begins Today at 4:30 p.m. Eastern Time"
02/17/2016 8-K Form 8-K - Current report
02/05/2016 8-K Form 8-K - Current report
01/29/2016 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ...
Docs: "Certificate of Amendment of Certificate of Incorporation"
01/27/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Press Release of CombiMatrix Corporation (furnished herewith pursuant to Item 7.01)"
12/24/2015 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12/07/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "CombiMatrix Corporation Transaction Bonus Plan",
"CombiMatrix Corporation Restated Executive Change of Control Severance Plan, as amended and restated on December 7, 2015"
11/04/2015 8-K Quarterly results
Docs: "CombiMatrix Corporation Reports Third Quarter 2015 Financial and Operating Results Growth in Revenue and Test Volumes Driven by Miscarriage Analysis and Pre-implantation Genetic Screening; Reports Narrowed Net Loss and Strong Cash Collections Conference Call Begins Today at 4:30 p.m. Eastern Time"
10/13/2015 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Form of Amendment No. 1 to February 2015 Common Stock Purchase Warrant",
"Form of Amendment No. 1 to April 2015 Common Stock Purchase Warrant",
"Form of Waiver of Cash Dividends"
08/05/2015 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CombiMatrix Corporation Reports Second Quarter 2015 Financial and Operating Results Marks 7th Consecutive Quarter of Record Prenatal Microarray Test Revenues and Volumes Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif. — CombiMatrix Corporation , a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal developmental disorders and pre-implantation genetic screening services, today reported financial results for the quarter and six months ended June 30, 2015, and provided a business update. “Our business momentum remains strong as evidenced by another quarter of record revenues and volume from our prenatal microarray diagnostic tests, as well as record cash collections” said Mark McDonough, CombiMatrix President and CEO. “Cont..."
06/19/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "CombiMatrix Corporation 2006 Stock Incentive Plan (as amended and restated June 17, 2015)"
05/07/2015 8-K Quarterly results
Docs: "CombiMatrix Reports First Quarter 2015 Financial and Operating Results"
04/29/2015 8-K Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission...
Docs: "Certificate of Amendment of Certificate of Incorporation"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy